Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications approved by the FDA for managing type 2 diabetes and, in some formulations, chronic weight management
6 Given the reduced appetite and potential for muscle loss, protein needs are generally higher for individuals on GLP-1 therapy compared to standard recommendations
And there are whats called the -gliprons, such as danuglipron and oroforglipron, that researchers are studying.1,15 As more people choose to take these weight management medications, RDs must educate themselves about them
Heres your step-by-step guide to starting GLP-1 treatment safely and effectively
For instance, the FDA approved Ozempic in March 2024 to prevent heart complications in overweight and obese adults
Standard tirzepatide titration Tirzepatide starts at 2.5mg weekly for the first four weeks, then increases to 5mg weekly